George R. Golding
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 25
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus 31
- Clostridium difficile and Clostridium perfringens research 12
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 6
-
- Streptococcal Infections and Treatments 9
-
- Infective Endocarditis Diagnosis and Management 8
- Microscopic Colitis 6
-
- Bacterial biofilms and quorum sensing 8
- Co-authors
- Michael R. MulveyCarol A. KellyRichard SparlingJennifer CampbellAndrew E. SimorSara ChristiansonPeter C. LoewenTamar Barkay
- Journals
- Journal of Antimicrobial Chemotherapy (6 papers)PLoS ONE (5 papers)Emerging infectious diseases (4 papers)
- Partner nations
- CanadaUnited StatesTrinidad and Tobago
In The Last Decade
George R. Golding
51 papers receiving 991 citations
Peers
Comparison fields: 5 of 85
- Clinical Biochemistry 344
- Infectious Diseases 608
- Molecular Medicine 129
- Applied Microbiology and Biotechnology 34
- Health, Toxicology and Mutagenesis 138
Countries citing papers authored by George R. Golding
This map shows the geographic impact of George R. Golding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George R. Golding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George R. Golding more than expected).
Fields of papers citing papers by George R. Golding
This network shows the impact of papers produced by George R. Golding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George R. Golding. The network helps show where George R. Golding may publish in the future.
Co-authorship network
The 25 scholars most cited alongside George R. Golding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 7 | |
| 8 | 2020 | 3 | |
| 9 | 2018 | 6 | |
| 10 | 2017 | 9 | |
| 11 | 2016 | 25 | |
| 12 | 2015 | 10 | |
| 13 | 2014 | 5 | |
| 14 | 2013 | 38 | |
| 15 | 2013 | 10 | |
| 16 | 2012 | 8 | |
| 17 | 2012 | 26 | |
| 18 | 2011 | 23 | |
| 19 | 2008 | 59 | |
| 20 | 2006 | 22 |
About George R. Golding
George R. Golding is a scholar working on Clinical Biochemistry, Infectious Diseases, Applied Microbiology and Biotechnology, Molecular Medicine and Endocrinology, having authored 52 papers that have together received 1.0k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (31 papers), Bacterial Identification and Susceptibility Testing (25 papers), Clostridium difficile and Clostridium perfringens research (12 papers), Streptococcal Infections and Treatments (9 papers), Infective Endocarditis Diagnosis and Management (8 papers), Bacterial biofilms and quorum sensing (8 papers), Antibiotic Resistance in Bacteria (6 papers) and Microscopic Colitis (6 papers). The work is most often cited by research in Clinical Biochemistry (344 citations), Infectious Diseases (608 citations), Molecular Medicine (129 citations), Applied Microbiology and Biotechnology (34 citations) and Health, Toxicology and Mutagenesis (138 citations). George R. Golding has collaborated with scholars based in Canada, United States and Trinidad and Tobago. Frequent co-authors include Michael R. Mulvey, Carol A. Kelly, Richard Sparling, Jennifer Campbell, Andrew E. Simor, Sara Christianson, Peter C. Loewen, Tamar Barkay, Ryan McDonald and Paul N. Levett. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, PLoS ONE, Emerging infectious diseases, Diagnostic Microbiology and Infectious Disease and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.